Brian E. Schultz

2.8k total citations · 1 hit paper
33 papers, 1.8k citations indexed

About

Brian E. Schultz is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Brian E. Schultz has authored 33 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Genetics. Recurrent topics in Brian E. Schultz's work include Photosynthetic Processes and Mechanisms (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Peptidase Inhibition and Analysis (4 papers). Brian E. Schultz is often cited by papers focused on Photosynthetic Processes and Mechanisms (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Peptidase Inhibition and Analysis (4 papers). Brian E. Schultz collaborates with scholars based in United States, United Kingdom and Switzerland. Brian E. Schultz's co-authors include Sunney I. Chan, R. H. Holm, Stacie A. Dalrymple, Peter R. Young, Stephen F. Gheller, Paul A. Sprengeler, Paul G. Grothaus, Douglas A. Jeffery, M. D. Sweeney and Jill M. Spoerke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Brian E. Schultz

33 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase

2006 517 citations Zhengying Pan, Heleen Scheerens et al. ChemMedChem profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian E. Schultz United States	18	881	422	379	268	266	33	1.8k
Laurie E. Grove United States	17	842 1.0×	95 0.2×	506 1.3×	102 0.4×	319 1.2×	35	1.6k
Andrew R. Thompsett United Kingdom	20	681 0.8×	363 0.9×	285 0.8×	121 0.5×	400 1.5×	34	1.6k
Sean O’Brien United States	25	2.0k 2.3×	129 0.3×	542 1.4×	384 1.4×	163 0.6×	48	3.3k
Huili Zhai United States	24	1.5k 1.7×	73 0.2×	411 1.1×	222 0.8×	79 0.3×	30	2.2k
Lisa Polin United States	32	1.6k 1.8×	111 0.3×	563 1.5×	583 2.2×	74 0.3×	102	3.0k
Daniella Zheleva United Kingdom	23	1.5k 1.8×	103 0.2×	830 2.2×	220 0.8×	112 0.4×	56	2.2k
Bingsen Zhou United States	33	2.2k 2.5×	74 0.2×	1.1k 2.9×	207 0.8×	114 0.4×	70	3.0k
Pingda Ren United States	21	2.3k 2.6×	307 0.7×	570 1.5×	636 2.4×	176 0.7×	49	3.2k
Yan Ling United States	23	1.0k 1.2×	79 0.2×	230 0.6×	251 0.9×	52 0.2×	60	1.8k
Walter A. Blättler United States	25	2.1k 2.3×	136 0.3×	2.4k 6.2×	306 1.1×	128 0.5×	37	4.5k

Countries citing papers authored by Brian E. Schultz

Since Specialization

Citations

This map shows the geographic impact of Brian E. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian E. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian E. Schultz more than expected).

Fields of papers citing papers by Brian E. Schultz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian E. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian E. Schultz. The network helps show where Brian E. Schultz may publish in the future.

Co-authorship network of co-authors of Brian E. Schultz

This figure shows the co-authorship network connecting the top 25 collaborators of Brian E. Schultz. A scholar is included among the top collaborators of Brian E. Schultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian E. Schultz. Brian E. Schultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liclican, Albert, Weimei Xing, Gregg Czerwieniec, et al.. (2020). Biochemical characterization of tirabrutinib and other irreversible inhibitors of Bruton's tyrosine kinase reveals differences in on - and off - target inhibition. Biochimica et Biophysica Acta (BBA) - General Subjects. 1864(4). 129531–129531. 74 indexed citations

Wong, Melanie, Alexandra B. Samal, Mike Lee, et al.. (2019). The KN-93 Molecule Inhibits Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity by Binding to Ca2+/CaM. Journal of Molecular Biology. 431(7). 1440–1459. 75 indexed citations

Appleby, T.C., Andrew E. Greenstein, Magdeleine Hung, et al.. (2017). Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9. Journal of Biological Chemistry. 292(16). 6810–6820. 76 indexed citations

Barauskas, Ona, Weimei Xing, Madeleine Willkom, et al.. (2017). Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Polymerase activity and mechanisms of action of nucleotide analogs. PLoS ONE. 12(10). e0185998–e0185998. 7 indexed citations

Xing, Weimei, Ona Barauskas, Thorsten Kirschberg, et al.. (2017). Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Endonuclease activity and evaluation of inhibitors. PLoS ONE. 12(8). e0181969–e0181969. 4 indexed citations

Liclican, Albert, Weimei Xing, Ting Wang, et al.. (2016). Biochemical Characterization of GS-4059 As a Potent and Selective Covalent Irreversible Inhibitor of Bruton's Tyrosine Kinase. Blood. 128(22). 1594–1594. 2 indexed citations

Feng, Joy Y., Yili Xu, Ona Barauskas, et al.. (2015). Role of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C Virus. Antimicrobial Agents and Chemotherapy. 60(2). 806–817. 62 indexed citations

Somoza, John R., David Koditek, Armando G. Villaseñor, et al.. (2015). Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase δ. Journal of Biological Chemistry. 290(13). 8439–8446. 119 indexed citations

Taylor, James G., T.C. Appleby, Ona Barauskas, et al.. (2015). P0899 : Preclinical profile of the pan-genotypic HCV NS3/4A protease inhibitor GS-9857. Journal of Hepatology. 62. S681–S681. 22 indexed citations

10.

Barauskas, Ona, Amoreena C. Corsa, Ruth Wang, et al.. (2014). Binding kinetics, potency, and selectivity of the hepatitis C virus NS3 protease inhibitors GS-9256 and vedroprevir. Biochimica et Biophysica Acta (BBA) - General Subjects. 1840(12). 3292–3298. 3 indexed citations

11.

Yang, Hai, Cheng Yong Yang, Gerry Rhodes, et al.. (2011). 779 PRECLINICAL CHARACTERIZATION OF THE NOVEL HCV NS3 PROTEASE INHIBITOR GS-9256. Journal of Hepatology. 54. S313–S313. 2 indexed citations

12.

Sprengeler, Paul A., Michael B. Shaghafi, Jeffrey R. Spencer, et al.. (2006). Discovery of novel hydroxy pyrazole based factor IXa inhibitor. Bioorganic & Medicinal Chemistry Letters. 16(10). 2796–2799. 12 indexed citations

13.

Pan, Zhengying, Heleen Scheerens, Shyr‐Jiann Li, et al.. (2006). Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase. ChemMedChem. 2(1). 58–61. 517 indexed citations breakdown →

14.

Cao, Zhe, Kathryn E. Bass, Sriram Balasubramanian, et al.. (2006). CRA-026440: a potent, broad-spectrum, hydroxamic histone deacetylase inhibitor with antiproliferative and antiangiogenic activity in vitro and in vivo. Molecular Cancer Therapeutics. 5(7). 1693–1701. 25 indexed citations

15.

Schultz, Brian E. & Sunney I. Chan. (2001). Structures and Proton-Pumping Strategies of Mitochondrial Respiratory Enzymes. Annual Review of Biophysics and Biomolecular Structure. 30(1). 23–65. 201 indexed citations

16.

Hansen, Kirk C., et al.. (2000). Reaction of Escherichia coli cytochrome bo3 and mitochondrial cytochrome bc1 with a photoreleasable decylubiquinol. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1456(2-3). 121–137. 20 indexed citations

17.

Schultz, Brian E. & Nei‐Li Chan. (1998). Thermodynamics of electron transfer in Escherichia coli cytochrome bo ₃. Proceedings of the National Academy of Sciences. 95(20). 11643–11648. 11 indexed citations

18.

Schultz, Brian E., Stephen F. Gheller, Mark C. Muetterties, Michael J. Scott, & R. H. Holm. (1993). Molybdenum-mediated oxygen-atom transfer: an improved analog reaction system of the molybdenum oxotransferases. Journal of the American Chemical Society. 115(7). 2714–2722. 139 indexed citations

19.

Schultz, Brian E., Stephen F. Gheller, Mark C. Muetterties, Michael J. Scott, & R. H. Holm. (1993). ChemInform Abstract: Molybdenum‐Mediated Oxygen Atom Transfer: An Improved Analogue Reaction System of the Molybdenum Oxotransferases.. ChemInform. 24(35). 5 indexed citations

20.

Krogsgaard‐Larsen, Povl, et al.. (1981). THIP, isoguvacine, isoguvacine oxide, and related GABA agonists.. PubMed. 29. 69–76. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact